A/Prof Mastura Monif
@masturamonif.bsky.social
Neurologist / Neuroimmunologist
Neuroscientist
Neuroscientist
Reposted by A/Prof Mastura Monif
NEW in @plosone.org promising #glioblastoma therapeutic target. Dr Matthew Drill & team
@masturamonif.bsky.social @monashuniversity.bsky.social
reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
@masturamonif.bsky.social @monashuniversity.bsky.social
reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma
Glioblastoma is the most common and aggressive form of primary brain cancer with a median survival of 15 months from diagnosis. The purinergic receptor P2X7 (P2X7R) is a regulator of several cell sign...
doi.org
September 19, 2025 at 4:54 AM
NEW in @plosone.org promising #glioblastoma therapeutic target. Dr Matthew Drill & team
@masturamonif.bsky.social @monashuniversity.bsky.social
reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
@masturamonif.bsky.social @monashuniversity.bsky.social
reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
Our public webinar Living with #Autoimmune #Encephalitis is now available on YouTube.
Thanks to Amber, Amanda & Michelle for their enormous courage to share their lived experiences of AE. I am sure the stories will resonate with many others.
@monashstm-grsc.bsky.social
youtu.be/S2B4fe7CwK0?...
Thanks to Amber, Amanda & Michelle for their enormous courage to share their lived experiences of AE. I am sure the stories will resonate with many others.
@monashstm-grsc.bsky.social
youtu.be/S2B4fe7CwK0?...
Living with Autoimmune Encephalitis
YouTube video by Translational Medicine, Monash University
youtu.be
April 18, 2025 at 12:55 AM
Our public webinar Living with #Autoimmune #Encephalitis is now available on YouTube.
Thanks to Amber, Amanda & Michelle for their enormous courage to share their lived experiences of AE. I am sure the stories will resonate with many others.
@monashstm-grsc.bsky.social
youtu.be/S2B4fe7CwK0?...
Thanks to Amber, Amanda & Michelle for their enormous courage to share their lived experiences of AE. I am sure the stories will resonate with many others.
@monashstm-grsc.bsky.social
youtu.be/S2B4fe7CwK0?...
#AutoimmuneEncephalitis can induce longlasting and pervasive impacts. On Tuesday 11th of March, we are hosting a webinar featuring those with lived experiences of AE.
Link below to register:
events.humanitix.com/understandin...
Link below to register:
events.humanitix.com/understandin...
Living with Autoimmune Encephalitis
Learn about autoimmune encephalitis & hear personal stories of coping & thriving while living with this rare condition.
events.humanitix.com
March 1, 2025 at 7:53 AM
#AutoimmuneEncephalitis can induce longlasting and pervasive impacts. On Tuesday 11th of March, we are hosting a webinar featuring those with lived experiences of AE.
Link below to register:
events.humanitix.com/understandin...
Link below to register:
events.humanitix.com/understandin...
Reposted by A/Prof Mastura Monif
Does progression occur independent of relapses (#PIRA) in neuromyelitis optica (#NMOSD)? Our PhD student Pakeeran Siriratnam examined this in real-world data & by tracking data on each progression event. @masturamonif.bsky.social @vjokubaitis.bsky.social
www.neurology.org/doi/10.1212/...
www.neurology.org/doi/10.1212/...
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD | Neurology
ObjectivesIn aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (AQP4-IgG
NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess
the prevalence of pr...
www.neurology.org
December 17, 2024 at 7:02 AM
Does progression occur independent of relapses (#PIRA) in neuromyelitis optica (#NMOSD)? Our PhD student Pakeeran Siriratnam examined this in real-world data & by tracking data on each progression event. @masturamonif.bsky.social @vjokubaitis.bsky.social
www.neurology.org/doi/10.1212/...
www.neurology.org/doi/10.1212/...
Reposted by A/Prof Mastura Monif
Alfred Health MSNI with Alfred Haematology is proud and excited to be one of two sites in Australia to offer #CARTcell therapy for aggressive relapsing and also progressive forms of #MS. @masturamonif.bsky.social
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology
This narrative review explores the current and future roles of chimeric antigen receptor (CAR) T-cell therapy in neurology, particularly for primary brain tumors and autoimmune neurological disorders.
jamanetwork.com
December 17, 2024 at 7:33 AM
Alfred Health MSNI with Alfred Haematology is proud and excited to be one of two sites in Australia to offer #CARTcell therapy for aggressive relapsing and also progressive forms of #MS. @masturamonif.bsky.social
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...